Startups
Cyted Health
Cyted Health develops and delivers molecular diagnostics for earlier detection of diseases of the esophagus. Its EndoSign capsule-sponge device collects esophageal cells without a conventional endoscopic procedure; laboratory biomarker testing and molecular analysis examine the sample for changes associated with Barrett’s esophagus, esophageal cancer and other conditions. The company combines cell collection, laboratory processing and test reporting to support clinicians’ diagnostic and surveillance decisions, with research using molecular characterization, statistical modeling and image-based machine learning to develop further tests. Its services are used in UK NHS and community settings, and it is expanding US laboratory and commercial operations. FDA 510(k) clearance applies to the EndoSign cell-collection device; it is not a blanket approval of every diagnostic assay. The Cyted Health brand covers Cyted Ltd and its UK and US subsidiaries.
Team
Adam DuckworthPathologist (historical; deceased) |
Basirat AfinowiHead of Projects |
Bruno HolthofInvestor Director |
Carmine CircelliInvestor Director |
Chris FreemanStrategic adviser (published appointment; current membership unverified) |
Chris HumberstonVP Finance |
Elizabeth HannaPublished company-directory team member (function not disclosed) |
Evan S. DellonScientific Advisory Board member |
Gail MarcusFormer Board Chair (departure publicly acknowledged September 2026) |
Jack SurmanVP People |
Jacques BergmanScientific Advisory Board member |
Jody CampbellVP Market Access |
Julian AbramsScientific Advisory Board member |
Kaasim MahmoodInvestor Director |
Keith FimanMedical Director, USA |
 Marcel GehrungCo-founder and Chief Executive Officer; Board Director |
Maria O’DonovanCo-founder and Lead Pathologist |
Mark HorsburghVP Software Engineering |
Matt MitchoChief Commercial Officer |
Neena MohanScientific Advisory Board member |
Neha GoelChief Operating Officer |
Nicholas J. ShaheenScientific Advisory Board member |
 Rebecca FitzgeraldCo-founder and Chair of Scientific Advisory Board |
Richard HardwickMedical Director, UK |
Robert Epstein (Cyted Health)Non-Executive Director |
Sachin WaniScientific Advisory Board member |
Sarah KillcoyneVP Biomarker Development |
Shirin HasanVP Clinical and Medical Affairs |
 Tim ReaInvestor Director |
Tom WestChair of Board and Non-Executive Director |
Will WestInvestor Director |